Sophiris Bio, Inc. (NASDAQ:SPHS) will report its next earnings on Mar 21 – Mar 27 (Est.). The company reported the earnings of $-0.17/Share in the last quarter where the estimated EPS by analysts was $-0.1/share. The difference between the expected and actual EPS was $-0.07/share, which represents an Earnings surprise of -70%.
Many analysts are providing their Estimated Earnings analysis for Sophiris Bio, Inc. and for the current quarter 2 analysts have projected that the stock could give an Average Earnings estimate of $-0.11/share. These analysts have also projected a Low Estimate of $-0.12/share and a High Estimate of $-0.1/share.
Some buy side analysts are also providing their Analysis on Sophiris Bio, Inc., where 0 analysts have rated the stock as Strong buy, 3 analysts have given a Buy signal, 0 said it’s a HOLD, 0 reported it as Underperform and 0 analysts rated the stock as Sell. (These Recommendations are for the Current Month Only reported by Yahoo Finance.)
When it comes to the Analysis of a Stock, Price Target plays a vital role. 3 Analysts reported that the Price Target for Sophiris Bio, Inc. might touch $8 high while the Average Price Target and Low price Target is $7 and $6 respectively.
To analyze a stock, one should look for Upgrades and Downgrades of a stock. Sophiris Bio, Inc. got Initiated on 13-Mar-17 where investment firm Rodman & Renshaw Initiated the stock to Buy.
Sophiris Bio, Inc. closed its last trading session at $2.42 with the gain of 14.46%. The Market Capitalization of the company stands at 85.84 Million. The Company has 52-week high of $8.55 and 52-week low of $0.8. The stock’s current distance from 20-Day Simple Moving Average (SMA20) is 4.92% where SMA50 and SMA200 are 0.23% and -6.09% respectively. The Company Touched its 52-Week High on Jul 26, 2016 and 52-Week Low on May 23, 2016.
The Relative Volume of the company is 3.49 and Average Volume (3 months) is 469.38 million. Sophiris Bio, Inc. P/E (price to earnings) ratio is 0 and Forward P/E ratio of 0.
The company shows its Return on Assets (ROA) value of -95.3%. The Return on Equity (ROE) value stands at -308.3%. While it’s Return on Investment (ROI) value is 0%.
While looking at the Stock’s Performance, Sophiris Bio, Inc. currently shows a Weekly Performance of 9.49%, where Monthly Performance is -1.77%, Quarterly performance is 0.73%, 6 Months performance is 2.59% and yearly performance percentage is 44.27%. Year to Date performance value (YTD perf) value is -1.07%. The Stock currently has a Weekly Volatility of 8.35% and Monthly Volatility of 5.33%.